Rchr
J-GLOBAL ID:201801017125684287   Update date: Nov. 08, 2024

Noguchi Yoshihiro

ノグチ ヨシヒロ | Noguchi Yoshihiro
Affiliation and department:
Job title: Associate Professor
Other affiliations (1):
  • Gifu Pharmaceutical University  Laboratory of Medical Collaborative Pharmacy (Satellite Laboratory in Ogaki Municipal Hospital) 
Homepage URL  (2): https://www.gifu-pu.ac.jp/lab/byoyaku/https://www.gifu-pu.ac.jp/english/
Research keywords  (11): drug interaction ,  Real World Data ,  Computational toxicology ,  Medical statistics ,  Drug informatics ,  Chemoinformatics ,  Bioinformatics ,  Pharmacoepidemiology ,  Pharmacovigilance ,  Regulatory science ,  appropriate use of pharmaceutical products
Research theme for competitive and other funds  (17):
  • 2022 - 2026 Construction of a safety signal search method for drug interactions with high evidence using big data
  • 2024 - 2025 「適切なセルフケア・セルフメディケーション」指標の創成と遠隔健康支援 への活用
  • 2024 - 2025 Creation of statistical analysis software (R package) for detection of drug-drug interaction signals
  • 2022 - 2023 Data-driven pharmacovigilance research for optimize cancer therapies
  • 2020 - 2023 Construction and effectiveness evaluation of drug education program to promote behavior change
Show all
Papers (127):
  • Kishi A, Noguchi Y, Tachi T, Iguchi K, Teramachi H. Questionnaire Survey on Stockpiling Medicines for Disasters in Pharmacies in Gifu City in Anticipation of Nankai Trough Earthquake. Disaster Medicine and Public Health Preparedness. 2024. 18. e259
  • Noguchi Y, Masuda R, Shishido M, Yoshimura T. Association between duration of action of benzodiazepine hypnotic drugs and blepharospasm: A disproportionality analysis study using FDA Adverse Events Reporting System. Journal of Evidence-Based Medicine. 2024. 17. 480-482
  • Xia S, Xu J, Yan K, Noguchi Y, Sarangdhar M, Yan M. Tumor lysis syndrome signal with the combination of encorafenib and binimetinib for malignant melanoma: a pharmacovigilance study using data from the FAERS database. Frontiers in Pharmacology. 2024. 15. 1413154
  • Masuda R, Noguchi Y, Aizawa H, Yoshizawa S, Nomura Y, Saguchi M, Iguchi K, Yoshimura T. Assessment of Cardiovascular Events Caused by New Generation Androgen Receptor Pathway Inhibitors Used for Prostate Cancer: A Real-World Study in Japan. Oncology. 2024
  • Noguchi Y, Tachi T, Yoshimura T. Caveats of Covariate Adjustment in Disproportionality Analysis for Best Practices. Drug Safety. 2024
more...
MISC (19):
  • Noguchi Y, Suzuki K, Ino Y, Yoshimura T. Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database. Clinical Drug Investigation. 2024. in press
  • Noguchi Y, Ino Y, Kobayashi R, Yoshimura T. Comment on: "Postmarketing adverse events of tamoxifen in male and female patients with breast cancer.". International Journal of Cancer. 2024. in press
  • Noguchi Y, Yoshimura T. Are demographic findings really possible from reports in a spontaneous reporting system?. Journal of Cystic Fibrosis. 2024. S1569-1993(24)00792-6
  • Noguchi Y, Yoshimura T. Comment on: "Drugs associated with epidermal necrolysis in children: A World Health Organization pharmacovigilance database analysis". Journal of the European Academy of Dermatology and Venereology. 2024
  • Noguchi Y, Yan M, Tachi T, Yoshimura T. Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Sayed et al. Journal for ImmunoTherapy of Cancer. 2024. 12. 4. e009137
more...
Books (4):
  • モデル・コアカリキュラムに沿った わかりやすい新実務実習テキスト2025-2026
    株式会社 じほう 2024 ISBN:9784840756129
  • モデル・コアカリキュラムに沿った わかりやすい新実務実習テキスト2023-2024
    株式会社 じほう 2022 ISBN:9784840754507
  • モデル・コアカリキュラムに沿った わかりやすい新実務実習テキスト2021-2022
    株式会社 じほう 2020 ISBN:9784840753074
  • モデル・コアカリキュラムに沿った わかりやすい新実務実習テキスト2019-2020
    株式会社 じほう 2019 ISBN:9784840751605
Lectures and oral presentations  (204):
  • オキサリプラチン誘発性末梢神経障害はナファモスタットメシル酸塩により抑制される
    (第34回日本医療薬学会年会 2024)
  • 地域薬剤師を対象としたリカレント講座受講後アンケート結果の年次推移の分析
    (第34回日本医療薬学会年会 2024)
  • 個別症例安全性報告データベース研究の適切な実施とその報告に必要なこと
    (第34回日本医療薬学会年会 2024)
  • 不眠症患者におけるメラトニン受容体作動薬と不整脈-ファーマコビジランスデータベースを用いた不均衡分析研究-
    (第34回日本医療薬学会年会 2024)
  • ベイジアンネットワークを用いた悪性リンパ腫患者の不安・副作用とQOLの因果関係究明
    (日本病院薬剤師会東海ブロック・日本薬学会東海支部合同学術大会2024 2024)
more...
Professional career (1):
  • Ph.D. (The United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University)
Work history (5):
  • 2023/04 - 現在 Gifu Pharmaceutical University Laboratory of Clinical Pharmacy associate professor
  • 2021/04 - 2023/03 Gifu Pharmaceutical University Laboratory of Clinical Pharmacy associate professor/lecturer
  • 2013/06 - 2023/03 Gifu Pharmaceutical University Pharmacy Pharmacist
  • 2013/06 - 2021/03 Gifu Pharmaceutical University Laboratory of Clinical Pharmacy Assistant professor
  • - 2013/05 Asahi University School of Dentistry Murakami Memorial Hospital Department of Pharmacy Pharmacist
Committee career (16):
  • 2024/04 - 現在 Frontiers in Psychiatry Guest Associate Editor
  • 2023/05 - 現在 Frontiers in Pharmacology Review Editor
  • 2023/01 - 現在 Frontiers in Medicine Review Editor
  • 2022/11 - 現在 Frontiers in Drug Safety and Regulation Guest Associate Editor (Section: in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology)
  • 2022/08 - 現在 READUS PV (Reporting of A Disproportionality analysis for drUg Safety signal detection using spontaneously reported adverse events in Pharmacovigilance) Group Multinational working committee
Show all
Awards (21):
  • 2024/04 - 日本薬学会第144年会 学生優秀発表賞
  • 2024/02 - NTTデータ数理システム学生研究奨励賞2023(敢闘賞)
  • 2023/11 - 日本病院薬剤師会東海ブロック・日本薬学会東海支部合同学術大会2023 ベストプレゼンテーション賞
  • 2022/11 - 日本病院薬剤師会東海ブロック・日本薬学会東海支部合同学術大会2022 ベストプレゼンテーション賞
  • 2022/10 - 日本社会薬学会第40年会 SP賞
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page